Cargando…

Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial results

BACKGROUND: To evaluate the diagnostic performance of radiomic signatures extracted from contrast-enhanced magnetic resonance imaging (CE-MRI) for the assessment of breast cancer receptor status and molecular subtypes. METHODS: One hundred and forty-three patients with biopsy-proven breast cancer wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leithner, Doris, Horvat, Joao V., Marino, Maria Adele, Bernard-Davila, Blanca, Jochelson, Maxine S., Ochoa-Albiztegui, R. Elena, Martinez, Danny F., Morris, Elizabeth A., Thakur, Sunitha, Pinker, Katja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739929/ https://www.ncbi.nlm.nih.gov/pubmed/31514736 http://dx.doi.org/10.1186/s13058-019-1187-z

Ejemplares similares

Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes
por: Leithner, Doris, et al.
Publicado: (2019)

Non-Invasive Assessment of Breast Cancer Molecular Subtypes with Multiparametric Magnetic Resonance Imaging Radiomics
por: Leithner, Doris, et al.
Publicado: (2020)

Multiparametric MRI model with dynamic contrast‐enhanced and diffusion‐weighted imaging enables breast cancer diagnosis with high accuracy
por: Zhang, Michelle, et al.
Publicado: (2018)

Radiomics for Tumor Characterization in Breast Cancer Patients: A Feasibility Study Comparing Contrast-Enhanced Mammography and Magnetic Resonance Imaging
por: Marino, Maria Adele, et al.
Publicado: (2020)

MRI evaluation of axillary and intramammary lymph nodes in the postoperative period
por: Horvat, Joao V., et al.
Publicado: (2019)

Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI
por: Avendano, Daly, et al.
Publicado: (2019)

Histogram Analysis and Visual Heterogeneity of Diffusion-Weighted Imaging with Apparent Diffusion Coefficient Mapping in the Prediction of Molecular Subtypes of Invasive Breast Cancers
por: Horvat, Joao V., et al.
Publicado: (2019)

A multiparametric [(18)F]FDG PET/MRI diagnostic model including imaging biomarkers of the tumor and contralateral healthy breast tissue aids breast cancer diagnosis
por: Leithner, Doris, et al.
Publicado: (2019)

Diffusion‐weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer
por: Horvat, Joao V., et al.
Publicado: (2019)

Assessing PD-L1 Expression Status Using Radiomic Features from Contrast-Enhanced Breast MRI in Breast Cancer Patients: Initial Results
por: Lo Gullo, Roberto, et al.
Publicado: (2021)

Pharmacokinetic Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging at 7T for Breast Cancer Diagnosis and Characterization
por: Ochoa-Albiztegui, R. Elena, et al.
Publicado: (2020)

Improved characterization of sub-centimeter enhancing breast masses on MRI with radiomics and machine learning in BRCA mutation carriers
por: Lo Gullo, Roberto, et al.
Publicado: (2020)

Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI
por: Daimiel Naranjo, Isaac, et al.
Publicado: (2020)

Imaging and the completion of the omics paradigm in breast cancer
por: Leithner, D., et al.
Publicado: (2018)

Breast Lesion Classification with Multiparametric Breast MRI Using Radiomics and Machine Learning: A Comparison with Radiologists’ Performance
por: Daimiel Naranjo, Isaac, et al.
Publicado: (2022)

Diagnostic value of radiomics and machine learning with dynamic contrast-enhanced magnetic resonance imaging for patients with atypical ductal hyperplasia in predicting malignant upgrade
por: Lo Gullo, Roberto, et al.
Publicado: (2021)

Radiomics and Machine Learning with Multiparametric Breast MRI for Improved Diagnostic Accuracy in Breast Cancer Diagnosis
por: Daimiel Naranjo, Isaac, et al.
Publicado: (2021)

MRI-based machine learning radiomics can predict HER2 expression level and pathologic response after neoadjuvant therapy in HER2 overexpressing breast cancer
por: Bitencourt, Almir G.V., et al.
Publicado: (2020)

Contrast-Enhanced Mammography for Screening Women after Breast Conserving Surgery
por: Gluskin, Jill, et al.
Publicado: (2020)

Abbreviated MRI of the Breast: Does It Provide Value?
por: Leithner, Doris, et al.
Publicado: (2018)

MRI background parenchymal enhancement, fibroglandular tissue, and mammographic breast density in patients with invasive lobular breast cancer on adjuvant endocrine hormonal treatment: associations with survival
por: Lo Gullo, Roberto, et al.
Publicado: (2020)

Fat Composition Measured by Proton Spectroscopy: A Breast Cancer Tumor Marker?
por: Bitencourt, Almir, et al.
Publicado: (2021)

Elevated glycine detected on in vivo magnetic resonance spectroscopy in a breast cancer patient: case report and literature review
por: Bitencourt, Almir G.V., et al.
Publicado: (2020)

Differentiation Between Benign and Metastatic Breast Lymph Nodes Using Apparent Diffusion Coefficients
por: Fardanesh, Reza, et al.
Publicado: (2022)

Multimodality Imaging of Breast Parenchymal Density and Correlation with Risk Assessment
por: Wengert, Georg J., et al.
Publicado: (2019)

Differences in degree of lesion enhancement on CEM between ILC and IDC
por: van Nijnatten, Thiemo JA, et al.
Publicado: (2019)

Conventional ultrasound and contrast-enhanced ultrasound radiomics in breast cancer and molecular subtype diagnosis
por: Gong, Xuantong, et al.
Publicado: (2023)

An A.I. classifier derived from 4D radiomics of dynamic contrast-enhanced breast MRI data: potential to avoid unnecessary breast biopsies
por: Pötsch, Nina, et al.
Publicado: (2021)

Automated Detection and Segmentation of Nonmass-Enhancing Breast Tumors with Dynamic Contrast-Enhanced Magnetic Resonance Imaging
por: Illan, Ignacio Alvarez, et al.
Publicado: (2018)

Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes
por: Huang, Chao, et al.
Publicado: (2019)

Biomineralogical signatures of breast microcalcifications
por: Kunitake, Jennie A. M. R., et al.
Publicado: (2023)

Lymph Node Imaging in Patients with Primary Breast Cancer: Concurrent Diagnostic Tools
por: Marino, Maria Adele, et al.
Publicado: (2019)

Iodine Map Radiomics in Breast Cancer: Prediction of Metastatic Status
por: Lenga, Lukas, et al.
Publicado: (2021)

A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer
por: Demircioglu, Aydin, et al.
Publicado: (2020)

Early recognition of necrotizing pneumonia in children based on non-contrast-enhanced computed tomography radiomics signatures
por: Chen, Xin, et al.
Publicado: (2021)

Potential of the Non-Contrast-Enhanced Chest CT Radiomics to Distinguish Molecular Subtypes of Breast Cancer: A Retrospective Study
por: Wang, Fei, et al.
Publicado: (2022)

Prediction of breast cancer molecular subtypes using radiomics signatures of synthetic mammography from digital breast tomosynthesis
por: Son, Jinwoo, et al.
Publicado: (2020)

Application of DCE-MRI radiomics signature analysis in differentiating molecular subtypes of luminal and non-luminal breast cancer
por: Huang, Ting, et al.
Publicado: (2023)

Radiomic Signature Based on Dynamic Contrast-Enhanced MRI for Evaluation of Axillary Lymph Node Metastasis in Breast Cancer
por: Tang, Yanqiu, et al.
Publicado: (2022)

A Multiparametric Fusion Radiomics Signature Based on Contrast-Enhanced MRI for Predicting Early Recurrence of Hepatocellular Carcinoma
por: Li, Wencui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9298qhhi56dgmq16rfnc8fuvg9